Depomed Yanks Diabetes Drug Glumetza

Law360, New York (June 17, 2010, 1:31 PM EDT) -- Drugmaker Depomed Inc. on Thursday recalled 52 lots of the diabetes medication Glumetza after finding trace amounts of 2,4,6-tribromoanisole, a chemical that is also linked to a recently expanded product recall by a Johnson & Johnson unit.

Menlo Park, Calif.-based Depomed said in a U.S. Securities and Exchange Commission filing that the recall was prompted by a complaint that a package of the 500 mg tablets had a smell and taste that is consistent with TBA, which is often used on wood pallets as a fungicide....
To view the full article, register now.